Fructose-1,6-bisphosphatase overexpression in pancreatic β-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of β-cell function.
Kebede, Melkam and Favaloro, Jenny and Gunton, Jenny E and Laybutt, D Ross and Shaw, Margaret and Wong, Nicole and Fam, Barbara C and Aston-Mourney, Kathryn and Rantzau, Christian and Zulli, Anthony and Prioietto, Joseph and Andrikopoulos, Sofianos (2008) Fructose-1,6-bisphosphatase overexpression in pancreatic β-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of β-cell function. Diabetes, 57 (7). pp. 1887-1895. ISSN 0012-1797Full text for this resource is not available from the Research Repository.
OBJECTIVE—Fructose-1,6-bisphosphatase (FBPase) is a gluconeogenic enzyme that is upregulated in islets or pancreatic beta-cell lines exposed to high fat. However, whether specific beta-cell upregulation of FBPase can impair insulin secretory function is not known. The objective of this study therefore is to determine whether a specific increase in islet beta-cell FBPase can result in reduced glucose-mediated insulin secretion. RESEARCH DESIGN AND METHODS—To test this hypothesis, we have generated three transgenic mouse lines overexpressing the human FBPase (huFBPase) gene specifically in pancreatic islet beta-cells. In addition, to investigate the biochemical mechanism by which elevated FBPase affects insulin secretion, we made two pancreatic beta-cell lines (MIN6) stably overexpressing huFBPase. RESULTS—FBPase transgenic mice showed reduced insulin secretion in response to an intravenous glucose bolus. Compared with the untransfected parental MIN6, FBPase-overexpressing cells showed a decreased cell proliferation rate and significantly depressed glucose-induced insulin secretion. These defects were associated with a decrease in the rate of glucose utilization, resulting in reduced cellular ATP levels. CONCLUSIONS—Taken together, these results suggest that upregulation of FBPase in pancreatic islet beta-cells, as occurs in states of lipid oversupply and type 2 diabetes, contributes to insulin secretory dysfunction.
|Uncontrolled Keywords:||ResPubID17605, ResPubID22034. Fructose-1,6-bisphosphatase (FBPase), pancreatic beta-cell lines, impairing insulin secretory function, increase in islet beta-cell FBPase, reduction of glucose-mediated insulin secretion|
|Subjects:||FOR Classification > 1101 Medical Biochemistry and Metabolomics
Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences
|Date Deposited:||31 Aug 2011 04:00|
|Last Modified:||23 Mar 2015 06:35|
|ePrint Statistics:||View download statistics for this item|
|Citations in Scopus:||21 - View on Scopus|
Repository staff only